BiotechTube
Nextera

Nextera

Oslo, Norway· Est.
nextera.no
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nextera is a private, preclinical-stage biotech company based in Oslo, Norway, founded in 2016. It has developed the NextCore platform, a unique pIX phage display technology, to generate highly specific TCR-like antibodies that target peptide-HLA (pHLA) complexes, aiming to unlock intracellular disease antigens for immunotherapy. The company is building a pipeline of lead candidates and operates a partnership-driven business model to develop therapies for complex diseases in oncology and autoimmunity. Leadership combines deep scientific expertise in antibody and TCR engineering with business development and financial experience from the biotech sector.

OncologyAutoimmune DiseasesInflammatory Diseases

Technology Platform

NextCore platform featuring a unique pIX phage display technology for discovering and engineering TCR-like antibodies that target peptide-HLA (pHLA) complexes to access intracellular disease antigens.

Opportunities

The TCR-mimic antibody space offers a vast, underexplored target landscape of intracellular antigens presented on pHLA, particularly in solid tumors.
A partnership-driven model can accelerate development, provide non-dilutive funding, and validate the platform through collaborations with established pharmaceutical companies.

Risk Factors

High scientific risk in generating safe, effective antibodies to challenging pHLA targets; intense competition from other TCR-focused biotechs; and financial dependency on external capital and partnership deals as a pre-revenue company.

Competitive Landscape

Nextera competes in the emerging TCR-mimic/therapeutics space against public companies like Immunocore (engineered TCRs) and Adaptimmune (TCR-T cells), as well as other biotechs developing pHLA-targeting antibodies. Differentiation hinges on the unique attributes of its NextCore pIX phage display platform.

More companies in Small Molecule Drugs →More companies in Norway →